An artificial pancreas system is safe and helped children as young as six with type 1 diabetes better control blood sugar levels, according to a new study from researchers at four pediatric diabetes centers in the United States. The study was published Wednesday in the New England Journal of Medicine.
The researchers studied 101 children between the ages of six and 13 for four months in a randomized clinical trial, comparing an experimental group using a new artificial pancreas system with a control group using a standard continuous glucose monitoring (CGM) device and a separate insulin pump.